The Current Ratio of Chengdu Easton Biopharmaceuticals Co Ltd (688513.SS) is 2.85.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2023-12-31 | 2.85 |
| 2022-12-31 | 3.23 |
| 2021-12-31 | 4.11 |
| 2020-12-31 | 4.92 |
| 2019-12-31 | 2.28 |
| 2018-12-31 | 2.74 |
| 2017-12-31 | 3.13 |